Feroz Khan Nun

Feroz Khan Nun

Auto-generated profile, based on publicly available information

Feroz Khan Nun

Department of Pharmacy Gopalganj Science and Technology University Gopalganj Bangladesh

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2025 in Journal of Medicinal Chemistry and Therapeutics
Verified
Journal Article
Open access
PDF file
FNFeroz Khan Nun
Feroz Khan Nun
SBSharif Uddin Bahar
Sharif Uddin Bahar
Md. Sakib Al HasanMd. Sakib Al Hasan
Md. Sakib Al Hasan
EMEmon Mia
Emon Mia
NYNoshin Tasnim Yana
Noshin Tasnim Yana
HSH. M. Shadid Hossain Snigdha
H. M. Shadid Hossain Snigdha
Sundarbans is a mangrove forest with plants containing compounds that exhibit various pharmacological properties, including antioxidant activity. This study used computational analysis to assess the antioxidant activity, binding potential, pharmacokinetics, drug-likeness, and several toxicities of phytochemicals from Sundarbans plants for potential treatments of oxidative damage. The findings revealed that compounds such as Rutin (RTN), Amentoflavone (AFE), Procyanidin (PYN), Lutein (LTN), Asiatic Acid (AC), Lupeol Caffeate (LCE), and Ursolic Acid (UA) showed significant antioxidant activity as well as higher binding potential –8.3, –8.9, –10.2, –8.5, –9.9, –9.6, and –10 kcal/mol, respectively. Additionally, these compounds demonstrated higher hydrogen bond (HB) formation, which is crucial for developing new drugs. Pharmacokinetic analysis showed RTN’s excellent solubility and bioavailability, while AFE, LCE, and PYN had moderate solubility. AC, AGN, and DGN exhibited high gastrointestinal absorption, with DGN having a blood-brain barrier, indicating neurological potential. All compounds demonstrated good intestinal absorption. None of the compounds inhibited cytochrome P450 enzymes, reducing drug-drug interaction risks. Toxicity predictions indicated most compounds were non-toxic, except UA, which showed hepatotoxicity, but no AMES toxicity or skin irritation was observed. These findings suggest that these compounds are promising bioactive agents for medicinal use, but further in vitro and in vivo studies, along with clinical investigations, are necessary to confirm their therapeutic potential and clarify their mechanisms of action.

28 March 2025 in Journal of Phytochemical Insights
Verified
Journal Article
Open access
PDF file
NBNishat Bahadur
Nishat Bahadur
ASAsit Baron Sarker
Asit Baron Sarker
DSDipongkar Ray Sobuj
Dipongkar Ray Sobuj
FNFeroz Khan Nun
Feroz Khan Nun
KAKhadija Akter
Khadija Akter
Md. Sakib Al HasanMd. Sakib Al Hasan
Md. Sakib Al Hasan
Phyla nodiflora (PNF), a medicinal plant, may offer a safer, more accessible alternative to synthetic drugs with fewer side effects. This study aimed to investigate the anti-diarrheal and thrombolytic properties of PNF leaf extract using in vivo and in vitro models, respectively. The anti-diarrheal activity of PNF was evaluated in Swiss albino mice using a castor oil-induced diarrhea model. Mice were administered PNF orally at 300 and 600 mg/kg, with loperamide (LOP) (3 mg/kg) as the positive control and distilled water (DW) as the negative control (NC). For thrombolytic activity, an in vitro clot lysis assay was conducted using human blood samples. Our result demonstrated that PNF possesses significant anti-diarrheal effects in a dose-dependent manner, reducing defecation by 27.27% and 63.64% at 300 and 600 mg/kg, respectively (p < 0.05), compared to 72.73% inhibition by LOP. Additionally, PNF exhibited notable clot lysis activity (44.59%), surpassing the NC (8.06%) but lower than streptokinase (STK) (74.25%) (p < 0.005). However, PNF leaf extract shows promising anti-diarrheal and thrombolytic activities, suggesting its potential as a natural therapeutic agent. Further research is needed to clarify its mechanisms and confirm clinical effectiveness.

10 March 2026 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
SAShakil Ahmmed
Shakil Ahmmed
TRTowfiqur Rahman
Towfiqur Rahman
TRTawfik Rakaiyat Ripu
Tawfik Rakaiyat Ripu
FNFeroz Khan Nun
Feroz Khan Nun
MAMohammad alshahrani
Mohammad alshahrani
Md. Sakib Al HasanMd. Sakib Al Hasan
Md. Sakib Al Hasan

2 June 2026 in Food Science & Nutrition
Verified
Journal Article
Open access
NYNoshin Tasnim Yana
Noshin Tasnim Yana
ACAnike Chakrabarty
Anike Chakrabarty
CSChinmoy Kumar Saha
Chinmoy Kumar Saha
NSN. Jamal Siddiqi
N. Jamal Siddiqi
NANorah Alnazhan
Norah Alnazhan
Azmat Ali KhanAzmat Ali Khan
Azmat Ali Khan
Insomnia is a disorder that involves dissatisfaction with sleep and difficulty falling or staying asleep. This study aims to explore the sedative activity of gallic acid (GA) on thiopental sodium (TS)‐induced sleep in mice. Intraperitoneal (i.p.) injections of GA (50, 100, and 200 mg/kg) and diazepam (DZP) (2 mg/kg) were given to Swiss albino mice individually or in combination. After administering TS, the onset and sleep duration were recorded. Additionally, GA's binding affinity (BA) with the GABA A receptor (α1 and β2 subunits) was examined using molecular docking. Results revealed that GA significantly ( p < 0.05) decreased onset and improved sleep duration in comparison to the control group in a dose‐dependent manner. The highest dose of GA (GA‐200) showed significant sedative activity with latency (1.77 ± 0.76 s) and sleep duration (182.28 ± 2.87 min). The combination of GA with DZP showed a synergistic sedative effect through decreasing latency and increasing sleep duration. In silico findings demonstrated that GA exhibited higher BA (−9.8 kcal/mol) against the GABA A receptor (α1 and β2 subunits) compared to DZP (−8.4 kcal/mol). It also exhibited good pharmacokinetic characteristics and was less toxic than the DZP. Overall, our in vivo and in silico studies suggest that GA showed promising sedative activity. However, further investigation, including clinical trials, is needed to discover its medicinal potential.